創薬アウトソーシング市場：ワークフロー、治療領域、タイプ、エンドユーザー別-2023-2030年の世界予測

創薬アウトソーシングの世界市場は大きく成長すると予測され、2023年には40億1,864万米ドルが予測され、CAGRは9.32%、2030年には驚異的な75億3,299万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の創薬アウトソーシング市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.創薬アウトソーシングの世界市場規模および予測は？

2.予測期間中、世界の創薬アウトソーシング市場を形成するCOVID-19の阻害要因と影響は？

3.創薬アウトソーシングの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.創薬アウトソーシングの世界市場における競争戦略は？

5.創薬アウトソーシングの世界市場における技術動向と規制の枠組みは？

6.創薬アウトソーシングの世界市場における主要ベンダーの市場シェアは？

7.創薬アウトソーシングの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • さまざまな慢性疾患の有病率の上昇とヘルスケア費の増加
    • 医薬品の研究開発投資の増加
    • ジェネリック医薬品と生物学的イノベーションに対する需要の高まり
  • 抑制要因
    • アウトソーシング時のコンプライアンス問題
  • 機会
    • 個別化医療への注目の高まり
    • 生物製剤パイプライン数の増加と受託製造サービスの拡大
  • 課題
    • 厳しい政府規制
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 創薬アウトソーシング市場：ワークフロー別

• リードの特定と候補の最適化
• 前臨床開発
• ターゲットの特定とスクリーニング
• ターゲットの検証と機能情報学

第7章 創薬アウトソーシング市場治療分野別

• 抗感染症
• 心臓血管
• 中枢神経系
• 皮膚科
• 内分泌
• 胃腸
• 泌尿器系
• 血液学
• 免疫調節
• 腫瘍学
• 眼科
• 痛みと麻酔
• 呼吸器系

第8章 創薬アウトソーシング市場：タイプ別

• 生物学サービス
• 化学サービス

第9章 創薬アウトソーシング市場：エンドユーザー別

• 学術機関
• 製薬およびバイオテクノロジー企業

第10章 南北アメリカの創薬アウトソーシング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の創薬アウトソーシング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの創薬アウトソーシング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. DRUG DISCOVERY OUTSOURCING MARKET RESEARCH PROCESS
• FIGURE 2. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2022 VS 2030
• FIGURE 3. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2022 VS 2030 (%)
• FIGURE 5. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2022 VS 2030 (%)
• FIGURE 6. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 7. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 8. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. DRUG DISCOVERY OUTSOURCING MARKET DYNAMICS
• FIGURE 10. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. DRUG DISCOVERY OUTSOURCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 5. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD IDENTIFICATION & CANDIDATE OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION & SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET VALIDATION & FUNCTIONAL INFORMATICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 10. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GENITOURINARY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY IMMUNOMODULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PAIN & ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESPIRATORY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 43. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 44. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 65. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 66. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 69. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 70. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 138. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 139. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 154. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 155. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 158. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 159. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 198. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 199. DRUG DISCOVERY OUTSOURCING MARKET LICENSE & PRICING

The Global Drug Discovery Outsourcing Market is forecasted to grow significantly, with a projected USD 4,018.64 million in 2023 at a CAGR of 9.32% and expected to reach a staggering USD 7,532.99 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Discovery Outsourcing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Discovery Outsourcing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Workflow, market is studied across Lead Identification & Candidate Optimization, Preclinical Development, Target Identification & Screening, and Target Validation & Functional Informatics. The Target Validation & Functional Informatics is projected to witness significant market share during forecast period.

Based on Therapeutics Area, market is studied across Anti-Infective, Cardiovascular, Central Nervous System, Dermatology, Endocrine, Gastrointestinal, Genitourinary System, Hematology, Immunomodulation, Oncology, Ophthalmology, Pain & Anesthesia, and Respiratory System. The Dermatology is projected to witness significant market share during forecast period.

Based on Type, market is studied across Biology Services and Chemistry Services. The Chemistry Services is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic Institutes and Pharmaceutical & Biotechnology companies. The Pharmaceutical & Biotechnology companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Discovery Outsourcing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Discovery Outsourcing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Discovery Outsourcing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Discovery Outsourcing Market?

4. What is the competitive strategic window for opportunities in the Global Drug Discovery Outsourcing Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Discovery Outsourcing Market?

6. What is the market share of the leading vendors in the Global Drug Discovery Outsourcing Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Discovery Outsourcing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Drug Discovery Outsourcing Market, by Workflow, 2022 vs 2030
• 4.3. Drug Discovery Outsourcing Market, by Therapeutics Area, 2022 vs 2030
• 4.4. Drug Discovery Outsourcing Market, by Type, 2022 vs 2030
• 4.5. Drug Discovery Outsourcing Market, by End-User, 2022 vs 2030
• 4.6. Drug Discovery Outsourcing Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of various chronic diseases coupled with rising healthcare expenditure
    • 5.1.1.2. Increasing pharmaceutical R&D investment
    • 5.1.1.3. Rising demand for generic drugs and biologic innovation
  • 5.1.2. Restraints
    • 5.1.2.1. Compliance issues while outsourcing
  • 5.1.3. Opportunities
    • 5.1.3.1. Increased focus on personalized medicine
    • 5.1.3.2. Growing number of biologics pipeline and growing contract manufacturing service
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government regulations
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Drug Discovery Outsourcing Market, by Workflow

• 6.1. Introduction
• 6.2. Lead Identification & Candidate Optimization
• 6.3. Preclinical Development
• 6.4. Target Identification & Screening
• 6.5. Target Validation & Functional Informatics

7. Drug Discovery Outsourcing Market, by Therapeutics Area

• 7.1. Introduction
• 7.2. Anti-Infective
• 7.3. Cardiovascular
• 7.4. Central Nervous System
• 7.5. Dermatology
• 7.6. Endocrine
• 7.7. Gastrointestinal
• 7.8. Genitourinary System
• 7.9. Hematology
• 7.10. Immunomodulation
• 7.11. Oncology
• 7.12. Ophthalmology
• 7.13. Pain & Anesthesia
• 7.14. Respiratory System

8. Drug Discovery Outsourcing Market, by Type

• 8.1. Introduction
• 8.2. Biology Services
• 8.3. Chemistry Services

9. Drug Discovery Outsourcing Market, by End-User

• 9.1. Introduction
• 9.2. Academic Institutes
• 9.3. Pharmaceutical & Biotechnology companies

10. Americas Drug Discovery Outsourcing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Drug Discovery Outsourcing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Outsourcing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing